Key Considerations To Managing Patient-Centric Trials

In recent years, the healthcare sector has seen a significant shift towards patient-centered care, advocating for a more inclusive and personalized approach. The U.S. Food & Drug Administration (FDA) has taken a proactive stance by issuing guidance on diversity, equity, and inclusion (DEI) in clinical trials, signaling a commitment to advancing patient-centric practices. While patient-centered care has long been emphasized in traditional healthcare settings, its importance extends seamlessly into clinical trials. However, despite growing recognition, many trials still lag in integrating patient feedback and perspectives.

This article explores the essence of patient-centric clinical trials, emphasizing the need for proactive engagement with patients and caregivers. Through insights from experts and FDA recommendations, delve into strategies for setting up inclusive trials and executing them with a patient-centric focus.